425 related articles for article (PubMed ID: 27838148)
1. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
2. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.
Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L
J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
[TBL] [Abstract][Full Text] [Related]
4. Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Borggreve AS; Heethuis SE; Boekhoff MR; Goense L; van Rossum PSN; Brosens LAA; van Lier ALHMW; van Hillegersberg R; Lagendijk JJW; Mook S; Ruurda JP; Meijer GJ
Eur Radiol; 2020 Apr; 30(4):1896-1907. PubMed ID: 31822974
[TBL] [Abstract][Full Text] [Related]
5. ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients.
Chen Y; Xie T; Ye Z; Wang F; Long D; Jiang M; Fang J; Lin Q; Li K; Wang Z; Fu Z
Radiat Oncol; 2019 Nov; 14(1):192. PubMed ID: 31684999
[TBL] [Abstract][Full Text] [Related]
6. Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Qiu B; Wang D; Yang H; Xie W; Liang Y; Cai P; Chen Z; Liu M; Fu J; Xie C; Liu H
Radiother Oncol; 2016 Nov; 121(2):239-245. PubMed ID: 27793445
[TBL] [Abstract][Full Text] [Related]
7. Investigation of using diffusion-weighted magnetic resonance imaging to evaluate the therapeutic effect of esophageal carcinoma treatment.
Wang L; Han C; Zhu S; Shi G; Wang Q; Tian H; Kong J; Zhang A
Oncol Res Treat; 2014; 37(3):112-6. PubMed ID: 24685914
[TBL] [Abstract][Full Text] [Related]
8. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.
Zheng H; Ren W; Pan X; Zhang Q; Liu B; Liu S; He J; Zhou Z
J Magn Reson Imaging; 2018 Aug; 48(2):349-358. PubMed ID: 29297204
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging for predicting and detecting the early response to chemoradiotherapy of advanced esophageal squamous cell carcinoma.
Imanishi S; Shuto K; Aoyagi T; Kono T; Saito H; Matsubara H
Dig Surg; 2013; 30(3):240-8. PubMed ID: 23880636
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer.
Aoyagi T; Shuto K; Okazumi S; Shimada H; Kazama T; Matsubara H
Dig Surg; 2011; 28(4):252-7. PubMed ID: 21654173
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer.
Xu HD; Zhang YQ; Shen WY; Mao ZC
Tumori; 2018 Jun; 104(3):188-195. PubMed ID: 28362059
[TBL] [Abstract][Full Text] [Related]
14. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
15. Potentialities of multi-b-values diffusion-weighted imaging for predicting efficacy of concurrent chemoradiotherapy in cervical cancer patients.
Liu B; Ma WL; Zhang GW; Sun Z; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y
BMC Med Imaging; 2020 Aug; 20(1):97. PubMed ID: 32799809
[TBL] [Abstract][Full Text] [Related]
16. Esophageal carcinoma: Intravoxel incoherent motion diffusion-weighted MRI parameters and histopathological correlations.
Zhu S; Wei Y; Gao F; Li L; Liu Y; Huang Z; Tang H; Zheng D; Wei X; Sun T; Song B
J Magn Reson Imaging; 2019 Jan; 49(1):253-261. PubMed ID: 29734492
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
19. Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma.
Li FP; Wang H; Hou J; Tang J; Lu Q; Wang LL; Yu XP
Clin Radiol; 2018 Aug; 73(8):756.e17-756.e26. PubMed ID: 29731125
[TBL] [Abstract][Full Text] [Related]
20. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
